Evidence map›Paper›PMID 21775552›Full record

ArticleJournal of clinical microbiology2011

Clostridium clostridioforme and Atopobium minutum clinical isolates with vanB-type resistance in France.

Jean-Christophe Marvaud, Francine Mory, Thierry Lambert

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Journal of clinical microbiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 26 citations in OpenAlex.

  1. Gut microbes reports · 2026
    Article
  2. Article
  3. Article
  4. Fifty years devoted to anaerobes: historical, lessons, and highlights.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2024
    Review
  5. Characterization of vancomycin-resistanceJAC-antimicrobial resistance · 2023
    Article
  6. Therapeutic manipulation of the microbiota: past, present, and considerations for the future.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2016
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Jean-Christophe MarvaudEA4043 Centre d'Etudes Pharmaceutiques, Université Paris XI, 92296 Châtenay-Malabry Cedex, France.
Francine Mory
Thierry Lambert
Université Paris-Saclay · FRCentre de Médecine Préventive · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acquired vancomycin resistance in Gram-positive anaerobes has been reported only in Australia and Canada from rare vanB-positive stool samples in the absence of vancomycin-resistant enterococci (VRE). We report the emergence of VanB-type resistance in Clostridium clostridioforme and Atopobium minutum involved in human infections in France.

Indexed as

Genes, BacterialVancomycin ResistanceActinobacteriaClostridiumDNA, BacterialFranceGram-Positive Bacterial InfectionsHumansMaleMiddle AgedMolecular Sequence DataSequence Analysis, DNADNA, Bacterial

Identifiers

PMID21775552
PMCPMC3165563
OpenAlexW2127338590

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.